Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
Synopsis : BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the right relating to…
Synopsis: Consultant uro-oncologist and robotic surgeon Abhay Kumar of Medica Superspecialty Hospital (MSH) said this robot-assisted surgery allowed a surgeon to go…
Summary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
Summary – Lupin Diagnostics, a 100 percent subsidiary of Lupin Limited, has set up a state-of-the-art 45,000 sq. ft National Reference Laboratory…
Summary – U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422. It is a…
Summary : SPARC has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of…
Summary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
Italian drugmaker Recordati has agreed on a price for six-year-old EUSA Pharma. The Milan-based firm will pay €750m ($845 million) for EUSA’s…
Synopsis : SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer Sun Pharma Advanced Research Company (SPARC) gained…